Lars Fruergaard Jorgensen, the chief executive of once-highflying Danish drugmaker Novo Nordisk, is stepping down after eight years in the role, the maker of Ozempic and Wegovy drugs announced on Friday.
Why America’s dangerous need for imported food is a crisis waiting to happen
Food is not just a commodity; it’s also a pillar of national security.
